Latest Articles

Publication Date
Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment - targetedonc.com

Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment targetedonc.com

Published: Jan. 28, 2026, 10:02 p.m.
Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment - Targeted Oncology

Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment Targeted Oncology

Published: Jan. 28, 2026, 10:02 p.m.
Women lose 25% more of life to poor health as investment lags - FemTech World

Women lose 25% more of life to poor health as investment lags FemTech World

Published: Jan. 28, 2026, 2:01 p.m.
Genetic Study of Rare Endometrial Cancer Uncovers Potential Treatments | Newswise - Newswise

Genetic Study of Rare Endometrial Cancer Uncovers Potential Treatments | Newswise Newswise

Published: Jan. 28, 2026, 12:45 a.m.
Clinical and cost-effectiveness of medical management versus surgery for deep infiltrating endometriosis: synopsis from the DIAMOND RCT.

Deep endometriosis causes significant pain which adversely affects quality of life and utilises healthcare and wider societal resources. Laparoscopic excision of endometriosis has shown to improve pain symptoms in observational …

Published: Jan. 28, 2026, midnight
Maternal endometriosis: An independent risk factor for long-term infectious morbidity of the offspring.

Endometriosis, a debilitating disease characterized by chronic inflammation, might be associated with adverse pregnancy outcomes. However, the long-term health implications for offspring born to mothers with endometriosis remain inadequately explored. …

Published: Jan. 28, 2026, midnight
Endometriosis Treatment Market Forecast to Reach USD 3.98 Billion by 2034 - openPR.com

Endometriosis Treatment Market Forecast to Reach USD 3.98 Billion by 2034 openPR.com

Published: Jan. 27, 2026, 5:49 p.m.
HIF2A as a prognostic and clinical therapeutic target in ovarian clear cell carcinoma.

Ovarian clear cell carcinoma (CCC) is an aggressive subtype of ovarian cancer that is resistant to conventional chemotherapy, resulting in poor prognosis. CCC develops from endometriosis, which exposes tumor cells …

Published: Jan. 27, 2026, midnight
Genetic Study of Rare Endometrial Cancer Uncovers Potential Treatments - Yale School of Medicine

Genetic Study of Rare Endometrial Cancer Uncovers Potential Treatments Yale School of Medicine

Published: Jan. 26, 2026, 8:48 p.m.
Unlocking Personalized Endometrial Cancer Treatment: The Critical Role of the BBIRE Biobank in Sample Collection and Distribution - Frontiers

Unlocking Personalized Endometrial Cancer Treatment: The Critical Role of the BBIRE Biobank in Sample Collection and Distribution Frontiers

Published: Jan. 26, 2026, 2:14 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!